Catalent
CTLT
#1583
Rank
A$16.36 B
Marketcap
$90.16
Share price
-0.35%
Change (1 day)
23.52%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.94

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.93. In 2022 the company made an earnings per share (EPS) of $3.40 a decrease over its 2021 EPS that were of $4.90.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-156.99%
2022$3.40-30.58%
2021$4.9079.67%
2020$2.73114.12%
2019$1.27-15%
2018$1.5075.44%
2017$0.85-22.97%
2016$1.11-59.56%
2015$2.74282.05%
2014$0.72-378.2%
2013-$0.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.18-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.12-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.11 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.58-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA